Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

K. A. Papp; K. B. Gordon; R. G. Langley; M. G. Lebwohl; A. B. Gottlieb; S. Rastogi; R. Pillai; R. J. Israel

doi:10.1111/bjd.16464

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

K. A. Papp, K. B. Gordon, R. G. Langley, M. G. Lebwohl, A. B. Gottlieb, S. Rastogi, R. Pillai, R. J. Israel

Inernational Relations Division

Research output: Contribution to journal › Article › peer-review

59 Citations (Scopus)

Original language	English
Pages (from-to)	320-328
Number of pages	9
Journal	British Journal of Dermatology
Volume	179
Issue number	2
DOIs	https://doi.org/10.1111/bjd.16464
Publication status	Published - Aug 2018

ASJC Scopus Subject Areas

Dermatology

Access to Document

10.1111/bjd.16464

Fingerprint

Dive into the research topics of 'Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3'. Together they form a unique fingerprint.

Cite this

Papp, K. A., Gordon, K. B., Langley, R. G., Lebwohl, M. G., Gottlieb, A. B., Rastogi, S., Pillai, R., & Israel, R. J. (2018). Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. British Journal of Dermatology, 179(2), 320-328. https://doi.org/10.1111/bjd.16464

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. / Papp, K. A.; Gordon, K. B.; Langley, R. G. et al.
In: British Journal of Dermatology, Vol. 179, No. 2, 08.2018, p. 320-328.

Research output: Contribution to journal › Article › peer-review

Papp, KA, Gordon, KB, Langley, RG, Lebwohl, MG, Gottlieb, AB, Rastogi, S, Pillai, R & Israel, RJ 2018, 'Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3', British Journal of Dermatology, vol. 179, no. 2, pp. 320-328. https://doi.org/10.1111/bjd.16464

Papp KA, Gordon KB, Langley RG, Lebwohl MG, Gottlieb AB, Rastogi S et al. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3. British Journal of Dermatology. 2018 Aug;179(2):320-328. doi: 10.1111/bjd.16464

@article{498388d9ab29483dae00c9816233f140,

title = "Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3",

author = "Papp, {K. A.} and Gordon, {K. B.} and Langley, {R. G.} and Lebwohl, {M. G.} and Gottlieb, {A. B.} and S. Rastogi and R. Pillai and Israel, {R. J.}",

note = "Publisher Copyright: {\textcopyright} 2018 British Association of Dermatologists",

year = "2018",

month = aug,

doi = "10.1111/bjd.16464",

language = "English",

volume = "179",

pages = "320--328",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis

T2 - integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

AU - Papp, K. A.

AU - Gordon, K. B.

AU - Langley, R. G.

AU - Lebwohl, M. G.

AU - Gottlieb, A. B.

AU - Rastogi, S.

AU - Pillai, R.

AU - Israel, R. J.

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85052198325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052198325&partnerID=8YFLogxK

U2 - 10.1111/bjd.16464

DO - 10.1111/bjd.16464

M3 - Article

C2 - 29488226

AN - SCOPUS:85052198325

SN - 0007-0963

VL - 179

SP - 320

EP - 328

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this